133 related articles for article (PubMed ID: 37574583)
1. Palliative radiotherapy for hepatic tumors: a narrative review of indications and recommendations.
Pennock M; Klein J; Lock M
Ann Palliat Med; 2023 Nov; 12(6):1420-1446. PubMed ID: 37574583
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
4. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
7. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for liver metastases.
Mendez Romero A; Høyer M
Curr Opin Support Palliat Care; 2012 Mar; 6(1):97-102. PubMed ID: 22189625
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Klement RJ; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2021 Jul; 149(2):358-370. PubMed ID: 33682927
[TBL] [Abstract][Full Text] [Related]
11. Unresectable Intermediate-Size (3-5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial.
van der Lei S; Dijkstra M; Nieuwenhuizen S; Schulz HH; Vos DJW; Versteeg KS; Buffart TE; Swijnenburg RJ; de Vries JJJ; Bruynzeel AME; van den Tol MP; Scheffer HJ; Puijk RS; Haasbeek CJA; Meijerink MR;
Cardiovasc Intervent Radiol; 2023 Aug; 46(8):1076-1085. PubMed ID: 37430016
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
13. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
14. Palliative efficacy and local control of conventional radiotherapy for lung metastases.
Fleming C; Rimner A; Foster A; Woo KM; Zhang Z; Wu AJ
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S21-S27. PubMed ID: 28595431
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated radiation therapy as palliative management for symptomatic and local control of advanced thoracic malignancies.
Ahn GS; Bruggeman AR; Qiao EM; Moiseenko V; Ray X; Sharabi A; Murphy JD; Sandhu AP
Ann Palliat Med; 2021 Oct; 10(10):10360-10368. PubMed ID: 34670382
[TBL] [Abstract][Full Text] [Related]
16. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
17. Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy.
Kavanagh BD; Scheftera TE; Wersäll PJ
Front Radiat Ther Oncol; 2007; 40():415-426. PubMed ID: 17641524
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief.
Buwenge M; Macchia G; Arcelli A; Frakulli R; Fuccio L; Guerri S; Grassi E; Cammelli S; Cellini F; Morganti AG
J Pain Res; 2018; 11():2169-2178. PubMed ID: 30323651
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
Wang WJ; Chiou JF; Huang Y
J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
